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Background: In China, even though the prevalence of dyslipidemia among adults increased yearly and dyslipidemia
being an important risk factor for cardiovascular diseases among the Chinese population, however, the awareness,
treatment and control of dyslipidemia are at low levels, and only limited studies on the influence factors associated
with the awareness, treatment and control dyslipidemia in China have been carried out.
Methods: The analysis was based on a representative sample of 7138 adult subjects aged 18 ~ 79 years recruited from
a cross-sectional study of chronic disease and risk factors among adults in the Jilin province in 2012. Chi-square test
was used to compare the rates of dyslipidemia awareness, treatment and control between different characteristics
of participants. Multiple logistic regression analyses were performed separately for each group to explore the associations
between participants’ characteristics and dyslipidemia awareness, treatment and control.
Results: Among participants with dyslipidemia, 11.6% were aware of the diagnosis, 8.4% were receiving treatment, and
34.8% had dyslipidemia controlled. Increase in age and BMI≥ 24 kg/m2 were by far the strongest risk factors associated
with better awareness and treatment of dyslipidemia. Retirees were more likely to be aware of their dyslipidemia
condition (OR = 1.255; 95% CI: 1.046, 1.506) and to be receiving treatment (OR = 1.367; 95% CI: 1.114, 1.676) than manual
workers. A family history of dyslipidemia increased the likelihood of awareness (OR = 3.620; 95% CI: 2.816, 4.653) and
treatment (OR = 3.298; 95% CI: 2.488, 4.371) of dyslipidemia. Alcohol drinking and physical activity were associated with a
lower level of awareness and treatment.
Cigarette smokers (OR = 0.501; 95% CI: 0.349, 0.719) and those with BMI≥ 24 kg/m2 (OR = 0.480; 95% CI: 0.326, 0.706) who
received treatment were also associated with poor dyslipidemia control.
Conclusion: Our study highlights low levels of awareness, poor treatment and control of dyslipidemia among adults
aged 18 ~ 79 in the Jilin province. Promotion of healthy lifestyles and establishment of a comprehensive strategy of
screening, treatment and control of dyslipidemia is needed to reduce or prevent the risk of cardiovascular disease in
the Jilin province.
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In China, the prevalence of dyslipidemia among adults
increases yearly and dyslipidemia is now an important
risk factor for cardiovascular diseases in the Chinese
population [1,2]. The results from the Chinese National
and Health Survey in 2002 showed that the prevalence
of dyslipidemia in the Chinese population was 18.6% [3].
The study of Wang et al. [4] reported that the preva-
lence of dyslipidemia in the Beijing adult population was
56.1% in 2006. Luo et al. [5] reported that prevalence of
dyslipidemia was 52.72% among adults in northwestern
China in 2010. CVD is characterized by high morbidity
of stroke and low morbidity of coronary heart disease,
but morbidity and mortality of coronary heart diseases
have gradually increased in the last 20 years in China
[6]. The report of the third recalled sample survey on
the causes of death in China showed that in the last
15 years, the proportion of deaths from chronic diseases
among residents increased from 76.5% to 82.5% among
residents, and cardiovascular death was the first cause
[7]. It is apparent that China will continue to experience
significant increase in the prevalence of cardiovascular-
related morbidity and mortality, which has the potential
to create an enormous burden on the health care system
in the future [8].
Moreover, the asymptomatic characteristics of dyslip-
idemia contribute to the increased incidence of CVD
and sudden death, thus uncontrolled dyslipidemia is a
serious risk factor for cardiovascular events such as cor-
onary heart disease, cerebral ischemic attack, cerebral
infarction and peripheral vascular disease [9,10]. Large
clinical trials have demonstrated that the treatment of
dyslipidemia is effective in both primary and secondary
prevention of CVD [11,12]. Treating dyslipidemia can
reduce the risk of heart diseases by approximately 30%
over a 5-year period [12]. Surveys in China have showed
that the awareness, treatment and control of dyslipid-
emia is poor [1,8,13], and only limited studies on the
influencing factors associated with the awareness, treat-
ment and control of dyslipidemia in China have been
carried out.
The aims of this study were: (1) to estimate the aware-
ness, treatment, and control of dyslipidemia in the adult
population in the Jilin province; and (2) to determine the
influence factors associated with the awareness, treat-
ment and control of dyslipidemia in the adult population
in the Jilin province.
Materials and methods
Ethical statement
The study was approved by the Institutional Review
Board of the School of Public Health, Jilin University,
and all subjects participated in the study after making
signed informed consents.Study population
Data were obtained from the survey of chronic disease
and risk factors among adults in the Jilin province of
China in 2012. The investigation was a cross-sectional
study that aimed to assess chronic disease and associated
risk factors among different populations in different re-
gions of the Jilin province in China. The survey used a
multistage cluster random sampling method to select a
representative sample of permanent residents aged 18 to
79 years in nine different cities in the Jilin province. The
detailed sampling process has been published elsewhere
[14]. A total of 17,729 participants completed the survey
and examination after excluding some participants due
to incomplete blood lipid information. Among the
17,729 respondents, a total of 7,138 subjects had dyslip-
idemia and were included in the study.
Data collection
Questionnaire interview
The study used a personal health survey questionnaire
established by the School of Public Health, Jilin University.
A direct face-to-face questionnaire interview was carried
out by uniformly trained investigators.
The questionnaire provided the demographic informa-
tion (such as region, age, gender, level of education, oc-
cupation), health behaviors (such as smoking, drinking,
diet, physical activity), history of dyslipidemia in the past
one year, and the current treatment of dyslipidemia.
Anthropometric
After the questionnaire interview, participants underwent
anthropometric checks including height and weight.
Weight was measured early in the morning before re-
spondents had eaten, and each physical measurement
was completed by two people together.
Laboratory assay
Fasting blood samples of each respondent were drawn
by venipuncture to measure serum Total Cholesterol
(TC), High Density Lipoprotein Cholesterol (HDL-C),
Low Density Lipoprotein Cholesterol (LDL-C) and
Triglycerides (TG). The tools used for all blood samples
collection were from the same source. After collection, the
samples were placed in a cold chain system before being
collectively transported to a central laboratory. Blood sam-
ples were analyzed using MODULE P800 automated bio-
chemistry analyzer (ROCHE, USA).
Definitions
Dyslipidemia was defined according to the Chinese
guidelines on the prevention and treatment of dyslipid-
emia in adults (2007) [6]: TC ≥ 6.22 mmol/L (240 mg/
dL) as high; LDL-C ≥ 4.14 mmol/L (160 mg/dL) as high;
HDL-C < 1.04 mmol/L (40 mg/dL) as low; and TG ≥
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TC, and/or high LDL-C, and/or low HDL-C and/or high
TG, and/or having a history of dyslipidemia disease in the
past one year, and/or currently receiving treatment with
lipid-lowering medications was regarded as dyslipidemia.
Awareness of dyslipidemia was defined as a self-reported
diagnosis of dyslipidemia by a healthcare professional or
treatment with medications within the population defined
as having dyslipidemia. Treatment of dyslipidemia was
defined as using medications to treat dyslipidemia among
participants with dyslipidemia. Dyslipidemia was consid-
ered to be controlled among the population defined as
having dyslipidemia and being treated with medication
if TC < 6.22 mmol/L, LDL-C < 4.14 mmol/L, HDL-C ≥
1.04 mmol/L, and TG < 2.26 mmol/L.
Body mass index (BMI) was calculated as weight (kg)
divided by height (m2). Using BMI 24 kg/m2 as cut off
point, participants were broadly categorized into two
main groups: overweight or obesity being defined as
BMI ≥ 24 kg/m2, and underweight or normal being de-
fined as BMI < 24 kg/m2. Smoking was defined as having
smoked at least one cigarette per day in the past 30 days,
or past smokers even if they had exhibited complete ab-
stinence from cigarette use for at least one month [8,15].
Drinking was defined as drinking any kind of purchased
or homemade alcohol-containing beverages on average
more than once a week. Physical activity was defined as
walking, running, going to the gym or other conscious
exercise not less than once a week. Participants with a
family history of dyslipidemia and those who like to eat
animal-based foods and salted foods were ascertained by
questionnaire.
Statistical analysis
EpiData3.1 was used to establish a database from which
and the data was then exported to SPSS 16.0 software
for further statistical analyses. Chi-square (χ2) test was
used to compare the rates of dyslipidemia awareness,
treatment and control between different characteristics
of the participants. Multiple logistic regression analyses
were performed separately for each group to explore the
associations between participants’ characteristics and
dyslipidemia awareness, treatment and control. All stat-
istical tests were two-tailed and P-values ≤ 0.05 consid-
ered statistically significant.
Results
Characteristics of the study sample
Table 1 presents the characteristics of the dyslipidemia
subjects. Out of the 7319 study subjects, 50.1% were
from the urban region, 51.1% were men, 48.9% were
women, 30.4% were aged between 45 and 54, the mean
age was 50.50 ± 12.30 years, 69.0% attained a junior high
school or higher education, 88.0% were married, and52.4% were manual workers. In terms of BMI distribu-
tion, 67.9% were BMI ≥ 24 kg/m2. Only 4.9% had a fam-
ily history of dyslipidemia. The rate of smoking was
44.2%, and drinking was 33.7%, with 9.2% admitted eat-
ing more of animal-based foods, 40.4% more of salted
foods, and 42.3% of the study subjects reported having
regular exercises.
Awareness, treatment and control of dyslipidemia
Table 2 shows the prevalence of dyslipidemia awareness,
treatment and control. Among participants with dyslip-
idemia, 852 (11.6%) were aware of the diagnosis of their
condition, and the overall rate of dyslipidemia treatment
was 8.4%. Among the 615 dyslipidemia patients receiv-
ing medical treatment for dyslipidemia, 214 (34.8%) were
under control.
Awareness of dyslipidemia
The awareness of dyslipidemia increased with age (P <
0.001), with the last age group 65 ~ 79 having the highest
level of awareness, 130(14.5%). Awareness of dyslipid-
emia also differed significantly by gender with females
being more aware of their dyslipidemia than males (P =
0.018); education with participants who attained univer-
sity level of education being more aware of their condi-
tion compared to lower levels of education (P = 0.006);
There were significant differences between the occupa-
tions in awareness of dyslipidemia (P < 0.001), with re-
tired having the highest level of awareness, 332(15.2%).
BMI with subjects having BMI ≥ 24 kg/m2 being more
aware than those with BMI < 24 kg/m2 (P < 0.001); and
participants with family history of dyslipidemia had
higher levels of awareness of dyslipidemia compared to
those without any history of the condition (P < 0.001).
Smoking, drinking and physical activity were associated
with higher levels of dyslipidemia awareness (all P <
0.01). The awareness of dyslipidemia was not signifi-
cantly associated with residential area (P = 0.083), mari-
tal status (P = 0.058), or whether the participants like
more of animal-based foods (P = 0.055) or salted foods
(P = 0.184).
Treatment of dyslipidemia
The treatment rate increased with age (P < 0.001), with
the last age group 65 ~ 79 having the highest rate of
treatment, 101(11.2%); and differed significantly by gen-
der (P = 0.014) and occupation (P < 0.001) with females
and retired having higher treatment rates compared to
males and manual workers respectively. The level of dys-
lipidemia treatment was also significantly associated with
BMI and a family history of dyslipidemia (all P < 0.001)
with subjects with BMI ≥ 24 kg/m2 and those with a
family history of dyslipidemia having higher treatment
rates as against those with BMI < 24 kg/m2 or without a
Table 1 Characteristics of the study sample (n = 7319)
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Junior high school 2090 28.6






Manual workers 3832 52.4














Like to eat animal-based foods
No 6647 90.8
Yes 672 9.2
Like to eat salted foods
No 4363 59.6
Yes 2956 40.4
Table 1 Characteristics of the study sample (n = 7319)




He et al. Lipids in Health and Disease 2014, 13:122 Page 4 of 9
http://www.lipidworld.com/content/13/1/122family history of dyslipidemia respectively. Smoking
(P = 0.004), drinking (P < 0.001), liking to eat salted
foods (P = 0.035) and physical activity (P < 0.001) were
all associated with higher levels of dyslipidemia treat-
ment. In this present study, treatment of dyslipidemia
was not found to be significantly associated with resi-
dential area (P = 0.863), level of education (P = 0.146),
marital status (P = 0.328), or liking to eat animal-based
foods (P = 0.094) or salted foods (P = 0.035).
Control of dyslipidemia
Among dyslipidemia patients receiving medical treat-
ment for dyslipidemia, participants with BMI < 24 kg/m2
were more likely to have their dyslipidemia controlled
than those with BMI ≥ 24 kg/m2 (P < 0.001). Smoking
was associated with a lower level of dyslipidemia control
than non-smoking (P < 0.001).
Factors associated with awareness, treatment and control
of dyslipidemia
In a multivariate binary logistic regression analysis, aware-
ness, treatment, and control of dyslipidemia were used as
dependent variables; and the parameters which were signifi-
cantly associated with awareness, treatment, and control of
dyslipidemia in the χ2 test (P < 0.05 in Table 2), were used
as independent variables respectively.
As shown in Table 3, the prevalence of the awareness
of dyslipidemia was significantly associated with increas-
ing age, and there was a significant association between
education and the awareness of dyslipidemia. Retired
participants more likely to aware of their dyslipidemia con-
dition than manual workers (OR = 1.255; 95% CI: 1.046,
1.506). Subjects with BMI ≥ 24 kg/m2 tended to be more
aware of their dyslipidemia condition than those with
BMI < 24 kg/m2 (OR = 1.547; 95% CI: 1.307,1.832). In
addition, having a family history of dyslipidemia increased
the tendency of awareness of dyslipidemia (OR = 3.620;
95% CI: 2.816, 4.653). Alcohol drinkers (OR = 0.780; 95%
CI: 0.658, 0.925) or those who regularly do physical exer-
cises (OR = 0.714; 95% CI: 0.606, 0.842) were unlikely to be
aware of their dyslipidemia condition.
Table 4 illustrates that increasing age was significantly
associated with the treatment of dyslipidemia, with re-
tired (OR = 1.367; 95% CI: 1.114, 1.676) being more
likely to be treated than manual workers. The higher the
level of BMI the more likely that the respondent will
Table 2 Awareness, treatment and control of dyslipidemia by characteristics, 2012, Jilin province, China
Variables Awarenessa Treatmenta Controlb
N(%) P N(%) P N(%) P
Total 852(11.6) 615(8.4) 214(34.8)
Residential areas 0.083 0.863 0.075
Urban 449(12.3) 309(8.5) 97(31.4)
Rural 403(11.0) 306(8.3) 117(38.2)
Gender 0.018 0.014 0.058
Male 403(10.8) 285(7.6) 88(30.9)
Female 449(12.5) 330(9.2) 126(38.2)
Age group (years) <0.001 <0.001 0.886
18~ 24(2.9) 15(1.8) 4(26.7)
35~ 130(9.4) 87(6.3) 33(37.9)
45~ 283(12.7) 201(9.0) 72(35.8)
55~ 285(14.3) 211(10.6) 70(33.2)
65 ~ 79 130(14.5) 101(11.2) 35(34.7)
Education 0.006 0.146 0.075
Primary school or lower 225(9.9) 168(7.4) 63(37.5)
Junior high school 249(11.9) 192(9.2) 71(37.0)
Senior high school 238(12.2) 163(8.3) 59(36.2)
University 140(13.9) 92(9.2) 21(22.8)
Marital status 0.058 0.328 0.993
Married 767(11.9) 549(8.5) 191(34.8)
Single 85(9.7) 66(7.5) 23(34.8)
Occupation <0.001 <0.001 0.529
Manual workers 351(9.2) 253(6.6) 92(36.4)
Mental workers 169(13.0) 109(8.4) 33(30.3)
Retired 332(15.2) 253(11.6) 89(35.2)
BMI≥ 24 kg/m2 <0.001 <0.001 <0.001
No 206(8.8) 144(6.1) 69(47.9)
Yes 646(13.0) 471(9.5) 145(30.8)
Family history of dyslipidemia <0.001 <0.001 0.948
No 745(10.7) 541(7.8) 188(34.8)
Yes 107(29.7) 74(20.6) 26(35.1)
Smokers <0.001 0.004 <0.001
No 524(12.8) 377(9.2) 153(40.6)
Yes 328(10.1) 238(7.4) 61(25.6)
Drinking <0.001 <0.001 0.082
No 616(12.7) 454(9.4) 167(36.8)
Yes 236(9.6) 161(6.5) 47(29.2)
Like to eat animal-based foods 0.055 0.094 0.912
No 789(11.9) 570(8.6) 198(34.7)
Yes 63(9.4) 45(6.7) 16(35.6)
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Table 2 Awareness, treatment and control of dyslipidemia by characteristics, 2012, Jilin province, China (Continued)
Like to eat salted foods 0.184 0.035 0.061
No 490(11.2) 342(7.8) 130(38.0)
Yes 362(12.2) 273(9.2) 84(30.8)
Physical activity <0.001 <0.001 0.689
No 587(13.9) 423(10.0) 145(34.3)
Yes 265(8.6) 192(6.2) 69(35.9)
aamong all dyslipidemia subjects.
bamong those who received treatment.
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1.294, 1.918). Subjects with a family history of dyslipid-
emia were more likely than those without family history
to report drug treatment among participants with dyslip-
idemia (OR = 3.298; 95% CI: 2.488, 4.371).Table 3 Multivariate logistic regression analyses on
influence factors for awareness of dyslipidemia, 2012,
Jilin province, China
Variables Awarenessa
OR 95% CI P
Age group (years)
18- 1.000
35- 3.865 2.464,6.062 <0.001
45- 5.481 3.554,8.453 <0.001
55- 6.491 4.170,10.105 <0.001
65-79 6.420 3.989,10.332 <0.001
Education
Primary school or lower 1.000
Junior high school 1.425 1.165,1.743 0.001
Senior high school 1.361 1.095,1.691 0.005
University 1.835 1.366,2.466 <0.001
Occupation
Manual workers 1.000
Mental workers 1.083 0.848,1.384 0.521
Retired 1.255 1.046,1.506 0.014
BMI≥ 24 kg/m2
No 1.000
Yes 1.547 1.307,1.832 <0.001
Family history of dyslipidemia
No 1.000
Yes 3.620 2.816,4.653 <0.001
Drinking
No 1.000
Yes 0.780 0.658,0.925 0.004
Physical activity
No 1.000
Yes 0.714 0.606,0.842 <0.001
Method: Forward: LR; OR = odds ratio; CI = confidence interval.
aamong all dyslipidemia subjects.As shown in Table 5, among the study subjects with dys-
lipidemia who were treated with drugs, BMI ≥ 24 kg/m2
was associated with poor control of dyslipidemia (OR =
0.480; 95% CI: 0.326, 0.706). Smokers were less likely to
control their serum lipids at normal levels (OR = 0.501;
95% CI: 0.349, 0.719).Table 4 Multivariate logistic regression analyses on
influence factors for treatment of dyslipidemia, 2012,
Jilin province, China
Variables Treatmenta
OR 95% CI P
Age group (years)
18- 1.000
35- 3.816 2.184,6.669 <0.001
45- 5.338 3.126,9.112 <0.001
55- 6.043 3.519,10.377 <0.001
65-79 6.064 3.425,10.727 <0.001
Occupation
Manual workers 1.000
Mental workers 1.183 0.923,1.515 0.184
Retired 1.367 1.114,1.676 0.003
BMI≥ 24 kg/m2
No 1.000
Yes 1.575 1.294,1.918 <0.001
Family history of dyslipidemia
No 1.000
Yes 3.298 2.488,4.371 <0.001
Drinking
No 1.000
Yes 0.756 0.620,0.923 0.006
Like to eat salted foods
No 1.000
Yes 1.319 1.110,1.567 0.002
Physical activity
No 1.000
Yes 0.683 0.567,0.824 <0.001
Method: Forward: LR; OR = odds ratio; CI = confidence interval.
aamong all dyslipidemia subjects.
Table 5 Multivariate logistic regression analyses on
influence factors for control of dyslipidemia, 2012, Jilin
province, China
Variables Controlb
OR 95% CI P
BMI≥ 24 kg/m2
No 1.000
Yes 0.480 0.326,0.706 <0.001
Smoking
No 1.000
Yes 0.501 0.349,0.719 <0.001
Note: Method: Forward: LR; OR = odds ratio; CI = confidence interval.
bamong those who receiving treatment.
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With economic growth and associated changes in life-
style and diet, the level of serum cholesterol in the Chinese
population has greatly increased [4,16]. Dyslipidemia is a
major pathogenic factor of atherosclerosis, and one of
the independent risk factors for cardiovascular disease
such as coronary heart disease and stroke [1,5]. Increas-
ing the awareness and management of patients with
dyslipidemia has a positive impact on cardiovascular
disease prevention [11]. Despite this, numerous studies
have revealed poor awareness and unsatisfactory treat-
ment and control in many European countries [17], and
extremely low rates of dyslipidemia in the Chinese popula-
tion [3,6,8,13]. It has been reported that the awareness,
treatment, and control rates of dyslipidemia were com-
paratively low among Chinese adults aged 18 and above,
at 10.93%, 6.84% and 35.3% respectively in 2010 [1]. We
found similar results in this present study with rates of
awareness and treatment among participants being 11.6%
and 8.4% respectively. However, the rates in our study
were significantly less than the 22.2% awareness of diagno-
sis and 46.1% receiving treatment among adults in Beijing,
China in 2012 [8]. Out of the 615 dyslipidemia individuals
in our study that were receiving treatment, 34.8% were
under control. This is slightly lower than the 37.8% serum
lipids control finding of Cai et al. [8] among those with
dyslipidemia receiving treatment. This indicates that dys-
lipidemia is an important health risk factors in the Jilin
province. However, only limited studies on the influencing
factors associated with awareness, treatment and control
of dyslipidemia had been carried out in China. Hence our
study aimed to examine the awareness, treatment, and
control of dyslipidemia, and their influence factors in the
Jilin province.
Because dyslipidemia is almost asymptomatic and its
detection requires blood analysis which in most cases re-
quested by a physician, ordinary residents are hardly
aware of and being treated for dyslipidemia disease [17].
The results of our study revealed that the awareness andtreatment of dyslipidemia among our study population
increased concomitantly with age. This is in line with
other studies such as the rate of awareness among resi-
dents in Beijing being less than 15% among adults aged
45 and above [18], and the awareness rate also increas-
ing with age among residents in Laiwu city, China [19].
This means that as people advance in age, they become
more concerned about their health, particularly being
concerned about cardiovascular diseases, than younger
individuals who are less likely to attach great importance
to disease consciousness.
Several recent studies showed that education is posi-
tively associated with the awareness of dyslipidemia
[10,18,20,21]. The more an individual attains higher
levels of education, the more likely awareness about
health conditions, including dyslipidemia, increases. Re-
garding the determinants of awareness in our study, an
increasing education level was associated with a higher
level of dyslipidemia awareness.
Our study also showed that compared with manual
workers, retired participants were more likely to be
aware of their dyslipidemia condition and seek treat-
ment. This may be related to retirees, students having
more time to focus on their health, and tend to seek
early management of any adverse health condition.
However, manual workers always appear body fatigue
after a whole day’s work, so they easily ignore the condi-
tion body health.
Obesity is an independent risk factor of dyslipidemia
[17,22]. Findings from the ORISCAV-LUX study re-
vealed that obese subjects are more conscious of cardio-
vascular health risks than slim individuals. This is
helpful in increase their awareness of the underlying si-
lent metabolic pathologies associated with excess body
weight [17]. Our findings are consistent with other stud-
ies that overweight or obesity (BMI ≥ 24 kg/m2) is asso-
ciated with higher levels of dyslipidemia awareness and
treatment [19,20,23]. Individuals with BMI ≥ 24 kg/m2
tend to control their BMI at 24 kg/m2 or less, which
helps in preventing 50-60% risk of hypertriglyceridemia
in this population [24]. However, among individuals re-
ceiving treatment, individuals with BMI ≥ 24 kg/m2 are
less likely to have controlled dyslipidemia. This finding
is similar to the results of Long’s study in 2007 [22]. The
plausible explanation is that weight control is a lengthy
process, and it is more difficult to control blood lipids in
overweight or obese people.
People with a family history of dyslipidemia have a
higher risk of developing dyslipidemia [1]. In this study,
we found that family history of dyslipidemia was a strong
predictor of dyslipidemia awareness and treatment. Unsur-
prisingly, having a family member with dyslipidemia would
increase the consciousness and alertness of the whole fam-
ily with regards to dyslipidemia, and physicians tend to pay
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emia, as they tend to have increased risk of cardiovascular
diseases.
Consistent with other findings [19], our study revealed
physical activity is associated with lower levels of aware-
ness and treatment of dyslipidemia. This may be ex-
plained by the fact that people who exercise regularly
believe they are less likely to become sick, and therefore
are less likely to be conscious of dyslipidemia.
Lower levels of awareness and treatment were found
among alcohol drinkers and also lower levels of dyslipid-
emia control among cigarette smokers in the present
study. This may be explained that the dyslipidemia pa-
tients who are alcohol drinkers and cigarette smokers
usually receive advice on drinking and smoking cessation
given by physicians, or it may be associated with alcohol
drinkers and smokers’ lower level of concern about their
own health [18,25]. Several studies have found that life-
style changes are effective in controlling serum blood
lipids [8,19,26]. Thus it is important to emphasize the
need for policies that improve healthy lifestyle.
Study limitations
The findings should be interpreted with an understand-
ing of the following potential limitations. The cross-
sectional nature of our study design means that causal
associations can only be made with caution. As in many
surveys, our serum lipid levels and the definitions of
dyslipidemia awareness, treatment, and control were
based on measurements taken during a single visit. Po-
tential sources of bias include recall bias of self-reported
information. Treatment and control rates were based on
only pharmacological treatment of dyslipidemia, however, it
is possible to control serum lipid by non-pharmacological
means, such as diet and/or exercise. The Chinese criteria
were adopted to define dyslipidemia; therefore, we could
not directly compare our results with those from other
countries.
Conclusions
In conclusion, our study highlighted the low rates of
awareness, treatment and control of dyslipidemia among
adults aged 18–79 in the Jilin province, China. Continu-
ous efforts are needed to increase the awareness, treat-
ment and control of dyslipidemia taking influence
factors into account. Our results suggest that the rele-
vant departments should regularly carry out health edu-
cation programs on dyslipidemia. These departments
should also provide guidelines that help promote healthy
lifestyles such as increased physical activity, weight con-
trol, smoking cessation and cessation of alcohol drinking.
Establishment of a comprehensive strategy of screening,
treating and controlling of dyslipidemia is needed in the
Jilin Province. These interventions will help to reduce thehigh and increasing burden of cardiovascular disease in
the Jilin province, China.
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